Current Cancer Therapy Reviews
Volume 16, 4 Issues, 2020
ISSN: 1875-6301 (Online)
ISSN: 1573-3947 (Print)
This journal supports open access
ISSN: 1875-6301 (Online)
ISSN: 1573-3947 (Print)
This journal supports open access
Aims & Scope
Current Cancer Therapy Reviews publishes full-length review/mini reviews, original research articles, drug clinical trial studies and guest edited thematic issues on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.
Current Cancer Therapy Reviews
,Volume 16
-Number 1
Biography Open Access
Meet our Editorial Board Member
Preface Open Access
Preface
Editorial Open Access
Targeted Nanomedicines: In the Right Route Towards Improved Therapies
, 16(1): 3 - 4Guillermina Ferro-Flores
DOI: 10.2174/1573394715666181224144500
Targeted Nanomedicines: In the Right Route Towards Improved Therapies
Review Article
Recent Advances of Novel Therapeutic Agents from Botanicals for Prevention and Therapy of Breast Cancer: An Updated Review
, 16(1): 5 - 18Namrata Singh, Poonam Kushwaha*, Amresh Gupta and Om Prakash
DOI: 10.2174/1573394715666181129101502
Recent Advances of Novel Therapeutic Agents from Botanicals for Prevention and Therapy of Breast Cancer: An Updated Review
Review Article
Role of the Hsp90-Immunophilin Heterocomplex in Cancer Biology
, 16(1): 19 - 28Sonia A. De Leo, Nadia R. Zgajnar, Gisela I. Mazaira, Alejandra G. Erlejman and Mario D. Galigniana*
DOI: 10.2174/1573394715666190102120801
Role of the Hsp90-Immunophilin Heterocomplex in Cancer Biology
Review Article Open Access
Exploring Promises of siRNA in Cancer Therapeutics
, 16(1): 29 - 35Mahima Kaushik*, Rddhima Raghunand and Shobhit Maheshwari
DOI: 10.2174/1573394715666190207130128
Exploring Promises of siRNA in Cancer Therapeutics
Review Article
Key Signaling Pathways Engaged in Cancer Management: Current Update
, 16(1): 36 - 48Sanjiv Singh* and Rahul Shukla
DOI: 10.2174/1573394714666180904122412
Key Signaling Pathways Engaged in Cancer Management: Current Update
Review Article Open Access
Possible Biomarkers and Therapeutic Targets for the Management of Cervical Cancer
, 16(1): 49 - 61Sombeer Sharma, Aakash Deep*, Avtar C. Rana, Monu Yadav and Arun K. Sharma
DOI: 10.2174/1573394715666190126142508
Possible Biomarkers and Therapeutic Targets for the Management of Cervical Cancer
Articles Ahead of Print
Hepatoblastoma. Review of Pathology, Diagnosis and Modern Treatment Strategies
Adil Abdelhamed Abbas*, Alaa Mohammed – Noor Samkari and Abeer Salim Almehdar
DOI: 10.2174/1573394716666200206103826
View Abstract
Vagaries of the Host Response in the Development of Hepatitis B-related Hepatocellular Carcinoma: a Case Series
Peter Block, Brianna Shinn, Christopher Roth, Laurence Needleman, Ernest Rosato and Hie-Won Hann*
DOI: 10.2174/1573394716666200129121051
View Abstract
Drug Delivery Approaches for Doxorubicin in the Management of Cancers
Manish Vyas, Daniel Albert Simbo, Mohd. Mursalin, Vijay Mishra, Roqia Bashary and Gopal L. Khatik*
DOI: 10.2174/1573394716666191216114950
View Abstract
Development of MatLab Coding for Early Detection of Leukemia through Automated Analysis of RBCs
Durjoy Majumder*
DOI: 10.2174/1573394715666191204102545
View Abstract
Dickkopf-1 and β-catenin as Biomarkers for Early Diagnosis of Hepatocellular Carcinoma
Amal Ahmed Mohamed, Hala M. Ghanem, Maha M. Kamal, Rehab Ahmed, Naglaa Kamal Madkour, Dina Abdou, Soha M. Talima, Nehad Hawash and Sherief Abd-Elsalam*
DOI: 10.2174/1573394715666191122094659
View Abstract
Association of CA 15-3 and CEA with Liver Metastases in Patients with Breast Cancer
Akram Yazdani* and Hossein Akbari
DOI: 10.2174/1573394716666191216112938
View Abstract
Withdrawal Notice: The Prognostic Value of Prognostic Biomarkers in Esophageal Squamous Cell Carcinoma in Iranian Population
Mohammadreza Mirinezhad, Narjes Khalilipour, Reza Raoofian and Mohammad Reza Abbaszadegan*
DOI: 10.2174/1573394715666190206162002
View Abstract
New Researches about Combinatorial Therapeutic Regimen on Cancer Treatment
Xinjia He, Qiaqia He*, Lihua Wang and Xiaofei He
DOI: 10.2174/1573394715666190906125014
View Abstract
Modern Treatments for Gliomas Improve Outcome
Joshua Giambattista*, Egiroh Omene, Osama Souied and Fred H. C. Hsu
DOI: 10.2174/1573394715666191017153045
View Abstract
Brachial Plexopathy as a Complication of Radiotherapy: A Systematic Review
Dheyauldeen Shabeeb, Mansoor Kashavarz , Ahmed Eleojo Musa , Ehsan Mihandoost , Gholamreza Hassanzadeh , Mohammed Reza Hadian, Alireza Shirazi and Masoud Najafi *
DOI: 10.2174/1573394715666190724102937
View Abstract
Abstracts Ahead of Print
MiR-492 as an important biomarker for early diagnosis and targeted treatment in different cancers
Eskandar Taghizadeh*, Forough Taheri, Daryoush Rostami, Pedram Ghorbani Renani , Gordon A Ferns, Alireza Pasdar and Majid Ghayour Mobarhan
DOI: 10.2174/1573394716666200309124048
View Abstract
Exploring nanoemulsion for liver cancer therapy
Vaseem Ansari*, Usama Ahmad, Tanmay Upadhyay, Nazneen Sultana and Juber Akhtar
DOI: 10.2174/1573394716666200302123336
View Abstract
Immunoliposomes: Synthesis, Structure, and Their Potential as Drug Delivery Carriers
Divya Sandeep, Nour M. AlSawaftah and Ghaleb A. Husseini*
DOI: 10.2174/1573394716666200227095521
View Abstract
The magic roles of oncolytic viruses in common cancers treatments
Amir Mohamadi, Gilles Pagès and Mohammad Sadegh Hashemzadeh*
DOI: 10.2174/1573394716666200211120906
View Abstract
Published Contents
- Current Cancer Therapy Reviews, Volume 16, 2020
- Current Cancer Therapy Reviews, Volume 15, 2019
- Current Cancer Therapy Reviews, Volume 14, 2018
- Current Cancer Therapy Reviews, Volume 13, 2017
- Current Cancer Therapy Reviews, Volume 12, 2016
- Current Cancer Therapy Reviews, Volume 11, 2015
- Current Cancer Therapy Reviews, Volume 10, 2014
- Current Cancer Therapy Reviews, Volume 9, 2013
- Current Cancer Therapy Reviews, Volume 8, 2012
- Current Cancer Therapy Reviews, Volume 7, 2011
- Current Cancer Therapy Reviews, Volume 6, 2010
- Current Cancer Therapy Reviews, Volume 5, 2009
- Current Cancer Therapy Reviews, Volume 4, 2008
- Current Cancer Therapy Reviews, Volume 3, 2007
- Current Cancer Therapy Reviews, Volume 2, 2006
- Current Cancer Therapy Reviews, Volume 1, 2005
Editor's Choice
Identifying the Optimal Fractionation Schedules for Improved Response Rates and Survival in Patients with Metastatic Melanoma Treated with Ipilimumab and Radiotherapy
, 2020; 16(1): 78 - 85Jason Liu, Cong Xu, Junjia Zhu, Jeffrey Sivik, Joseph J. Drabick and Heath B. Mackley*
DOI: 10.2174/2542584601666180326111906
Serotonin (5HTR2A and 5HTR3A) and GABA (GABAB) Receptor Genes Overexpression are Correlated with Non-small Cell Lung Cancer (NSCLC)
, 2019; 15(2): 155 - 161Seyed A. Razavi, Besharat Rahimi, Naghmeh Gholipour, Fatemeh Ahangari and Ghasem Ahangari*
DOI: 10.2174/1573394714666180626155751
Cancer Chemotherapy by Novel Bio-active Natural Products: Looking Towards the Future
, 2019; 15(1): 37 - 49Om Prakash*, Shazia Usmani, Ruchi Singh, Debarshi K. Mahapatra and Amresh Gupta
DOI: 10.2174/1573394714666180321151315
Palliative Radiation of Chest Tumors
, 2018; 14(2): 149 - 166Katherine Barrett and Andrea Bezjak*
DOI: 10.2174/1573394714666180208141853
Stereotactic Body Radiation Therapy in Head and Neck Squamous Cell Carcinoma: Science or Art?
, 2018; 14(1): 68 - 74Rashi Garg and Omar Mahmoud*
DOI: 10.2174/1573394714666180122143310
Emerging Family of Protein-protein Interaction Inhibitors Targeting PD-1 Checkpoint Pathway
, 2017; 13(2): 120 - 128Yijun Huang* and Hong Zhang
DOI: 10.2174/1573394713666170824125158
Non-Melanoma Skin Cancer – Overview
, 2016; 12(3): 142 - 151Kurian Joseph
DOI: 10.2174/1573394713666161214124214
Recurrent Scalp Lesions from Glioblastoma: Case Report and Literature Review
, 2016; 12(2): 87 - 93Alisson R. Teles, Marcelo R. Roxo, Marcus V.M. Collares, Kelly R. Neves, Eduardo Cambruzzi and Marcelo P. Ferreira
DOI: 10.2174/1573394712666160926100147
Therapeutic Immunoconjugates. Which Cytotoxic Payload: Chemotherapeutic Drug (ADC) or Radionuclide (ARC) ?
, 2016; 12(1): 54 - 65Jean-François Chatal, Françoise Kraeber-Bodéré, Caroline Bodet-Milin and Caroline Rousseau
DOI: 10.2174/1573394712666160805121312
Radiotherapy in Transitional Cell Carcinoma of Urinary Bladder Cancer –Where Does it Fit Into Treatment Protocol
, 2015; 11(2): 94 - 101Rony Benson, Supriya Mallick, K.P. Haresh, P.K. Julka and G.K. Rath
DOI: 10.2174/1573394711666151022203201
Open Access Articles
Virtual Screening of Novel Hybrid Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Exploring Multiple Targeted Cancer Therapy by an In Silico Approach
, 2020; 16(1): 70 - 77Ashish P. Shah* and Chhagan N. Patel
Cancer Immunotherapy: An Effective Tool in Cancer Control and Treatment
, 2020; 16(1): 62 - 69Kawalpreet Kaur and Gopal L. Khatik*
Drug Delivery Approaches for Doxorubicin in the Management of Cancers
, 2020; 16: 1 - 13 (E-Pub Ahead of Print)Manish Vyas, Daniel Albert Simbo, Mohd. Mursalin, Vijay Mishra, Roqia Bashary and Gopal L. Khatik*
Solanum Nigrum Anticancer Effect Through Epigenetic Modulations in Breast Cancer Cell Lines
, 2019; 15: 1 - 6 (E-Pub Ahead of Print)Atefeh Shirkavand, Zahra Niki Boroujeni and Seyed Ahmad Aleyasin*
Overview of Modern Surgical Management of Central Nervous System Tumors: North American Experience
, 2019; 15: 1 - 14 (E-Pub Ahead of Print)Adam Wu*
Demographic and Clinical Evaluation of Patients with Pancreatic Cancer in Mashhad University of Medical Sciences During 2002-2013
, 2019; 15: 1 - 9 (E-Pub Ahead of Print)Mina Akbari Rad, Azar Fanipakdel, Hassan Vossoughinia, Maliheh Dadgarmoghaddam, Benyamin Esmaeili, Amir Hossein Jafarian, Masoumeh Salari* and Abdollah Firoozi
Brachial Plexopathy as a Complication of Radiotherapy: A Systematic Review
, 2019; 15: 1 - 11 (E-Pub Ahead of Print)Dheyauldeen Shabeeb, Mansoor Kashavarz , Ahmed Eleojo Musa , Ehsan Mihandoost , Gholamreza Hassanzadeh , Mohammed Reza Hadian, Alireza Shirazi and Masoud Najafi *
Molecular Pathways, Screening and Follow–up of Colorectal Carcinogenesis: An Overview
, 2019; 15: 1 - 9 (E-Pub Ahead of Print)Amirhossein Sahebkar *, Eskandar Taghizadeh, Seyed Mohammad Gheibi Hayat, Rhonda J. Rosengren and Hamed Abdolkarimi
Development, Characterization and Anticancer Evaluation of Silver Nanoparticles from Dalbergia Sissoo Leaf Extracts
, 2019; 15: 1 - 7 (E-Pub Ahead of Print)Aakash Deep*, Mitali Verma, Rakesh Kumar Marwaha, Arun Kumar and Beena Kumari
A Comparison of Ultrasound and Fluoroscopy- Guided Celiac Plexus Neurolysis in Patients With Pancreatic Cancer
, 2019; 15: 1 - 7 (E-Pub Ahead of Print)Khadeja M. Elhossieny, Waseem M. Seleem, Sherief Abd-Elsalam*, Tamer Haydara and Nashwa Mohamed El gharbawy
New Researches about Combinatorial Therapeutic Regimen on Cancer Treatment
, 2019; 15: 1 - 14 (E-Pub Ahead of Print)Xinjia He, Qiaqia He*, Lihua Wang and Xiaofei He
Dickkopf-1 and β-catenin as Biomarkers for Early Diagnosis of Hepatocellular Carcinoma
, 2019; 15: 1 - 9 (E-Pub Ahead of Print)Amal Ahmed Mohamed, Hala M. Ghanem, Maha M. Kamal, Rehab Ahmed, Naglaa Kamal Madkour, Dina Abdou, Soha M. Talima, Nehad Hawash and Sherief Abd-Elsalam*
Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target
, 2017; 13(2): 76 - 88Bently P. Doonan, Kei Ohnuma, Long H. Dang, Chikao Morimoto and Nam H. Dang*
In Silico Study and Cytotoxicity of the Synthesized Open-chain Analogues of Antimycin A3 Against HEP-2 Laryngeal Cancer Cells
, 2017; 13(2): 129 - 136Ade Arsianti*, Fadilah Fadilah, Kusmardi Kusmardi, Gede Y. Sugiarta, Hiroki Tanimoto and Kiyomi Kakiuchi
Most Cited Articles
Letter
The cancer hygiene hypothesis: From theory to therapeutic helminths
, 2019; 15(3): 248-250.Ruben Fernandes, Helena Alves and Monica C. Botelho*
DOI: 10.2174/1573394714666181003143717
Research Article
Virtual screening of novel hybrid non-steroidal anti-inflammatory drugs (Nsaids): Exploring multiple targeted cancer therapy by an in silico approach
, 2020; 16(1): 70-77.Ashish P. Shah* and Chhagan N. Patel
DOI: 10.2174/1573394715666190618114748
Review Article
Possible biomarkers and therapeutic targets for the management of cervical cancer
, 2020; 16(1): 49-61.Sombeer Sharma, Aakash Deep*, Avtar C. Rana, Monu Yadav and Arun K. Sharma
DOI: 10.2174/1573394715666190126142508
Editorial
Targeted nanomedicines: In the right route towards improved therapies
, 2020; 16(1): 3-4.Guillermina Ferro-Flores
DOI: 10.2174/1573394715666181224144500
Research Article
Identifying the optimal fractionation schedules for improved response rates and survival in patients with metastatic melanoma treated with ipilimumab and radiotherapy
, 2020; 16(1): 78-85.Jason Liu, Cong Xu, Junjia Zhu, Jeffrey Sivik, Joseph J. Drabick and Heath B. Mackley*
DOI: 10.2174/2542584601666180326111906
Review Article
Role of the Hsp90-immunophilin heterocomplex in cancer biology
, 2020; 16(1): 19-28.Sonia A. De Leo, Nadia R. Zgajnar, Gisela I. Mazaira, Alejandra G. Erlejman and Mario D. Galigniana*
DOI: 10.2174/1573394715666190102120801
Review Article
Recent advances of novel therapeutic agents from botanicals for prevention and therapy of breast cancer: An updated review
, 2020; 16(1): 5-18.Namrata Singh, Poonam Kushwaha*, Amresh Gupta and Om Prakash
DOI: 10.2174/1573394715666181129101502
Review Article
Exploring promises of siRNA in cancer therapeutics
, 2020; 16(1): 29-35.Mahima Kaushik*, Rddhima Raghunand and Shobhit Maheshwari
DOI: 10.2174/1573394715666190207130128
Review Article
Key signaling pathways engaged in cancer management: Current update
, 2020; 16(1): 36-48.Sanjiv Singh* and Rahul Shukla
DOI: 10.2174/1573394714666180904122412
Review Article (Mini-Review)
Cancer immunotherapy: An effective tool in cancer control and treatment
, 2020; 16(1): 62-69.Kawalpreet Kaur and Gopal L. Khatik*
DOI: 10.2174/1573394715666190913184853
Research Article
In silico analysis and molecular docking studies of novel 6,7-dihydro-pyrano [2,3-d] pyrimidin-5-one derivatives as human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR) inhibitors
, 2019; 15(3): 235-247.Ishan I. Panchal*, Ashish Shah, Animesh Devgirkar, Umang Shah, Ashish Patel, Alkesh Patel and Dhrubo J. Sen
DOI: 10.2174/1573394715666181129104528
Research Article
Main nutritional and environmental risk factors in children with leukemia from a public hospital of the State of Guanajuato, Mexico
, 2019; 15(3): 207-214.Rebeca Monroy-Torres*, Daniela Ibarra-Miranda, Jaime Naves Sánchez and Angela Castillo-Chávez
DOI: 10.2174/1573394714666181008151217
Research Article
Crocins: The active constituents of crocus sativus l. stigmas, exert significant cytotoxicity on tumor cells in vitro
, 2019; 15(3): 225-234.Kyriaki Hatziagapiou, Eleni Kakouri, George I. Lambrou, Eleni Koniari, Charalabos Kanakis, Olti A. Nikola, Margarita Theodorakidou, Konstantinos Bethanis and Petros A. Tarantilis*
DOI: 10.2174/1573394714666181029120446
Research Article
A model for heterogeneous brain tumor cells that cause dizziness
, 2019; 15(3): 215-224.Mohammad Farnush*
DOI: 10.2174/1573394714666180907152741
Most Accessed Articles
Efficacy and Safety of Targeting Androgen Receptor in Advanced Breast Cancer: A Systematic Review
, 2019; 15(3): 197-206.Loay Kassem, Kyrillus S. Shohdy*, Nafie F. Makady, Dalal S. Salem, Nadia Ebrahim and Mostafa Eldaly
DOI: 10.2174/1573394714666180821145032
Crocetin as an Active Secondary Metabolite of Saffron Stigma and Anticancer Effects
, 2019; 15(3): 192-196.Ali Farahi, Homa Mollaei* and Reyhane Hoshyar*
DOI: 10.2174/1573394714666180626154833
A Model for Heterogeneous Brain Tumor Cells that Cause Dizziness
, 2019; 15(3): 215-224.Mohammad Farnush*
DOI: 10.2174/1573394714666180907152741
Main Nutritional and Environmental Risk Factors in Children with Leukemia from a Public Hospital of the State of Guanajuato, Mexico
, 2019; 15(3): 207-214.Rebeca Monroy-Torres*, Daniela Ibarra-Miranda, Jaime Naves Sánchez and Angela Castillo-Chávez
DOI: 10.2174/1573394714666181008151217
Immunology Behind Tumors: A Mini Review
, 2019; 15(3): 174-183.Pooja Hurkat, Sourabh Jain, Richa Jain and Aakanchha Jain*
DOI: 10.2174/1573394714666180907143433
Anti-angiogenic Treatment in Metastatic Colorectal Cancer: Current Issues and Future Aims
, 2019; 15(3): 184-191.Martini Giulia, Troiani Teresa, Cardone Claudia, Vitiello Pietro Paolo, Ciardiello Davide, Morgillo Floriana, Ciardiello Fortunato and Martinelli Erika*
DOI: 10.2174/1573394714666181119145327
Crocins: The Active Constituents of Crocus Sativus L. Stigmas, Exert Significant Cytotoxicity on Tumor Cells In Vitro
, 2019; 15(3): 225-234.Kyriaki Hatziagapiou, Eleni Kakouri, George I. Lambrou, Eleni Koniari, Charalabos Kanakis, Olti A. Nikola, Margarita Theodorakidou, Konstantinos Bethanis and Petros A. Tarantilis*
DOI: 10.2174/1573394714666181029120446
New Agents – Manifold Consequences: The Management of Lung and Colorectal Cancer is Changing
, 2009; 5(1): 1-19.Christine Armbruster
DOI: 10.2174/157339409787314072
In Silico Analysis and Molecular Docking Studies of Novel 6,7-dihydropyrano [2,3-d] pyrimidin-5-one Derivatives as Human Epidermal Growth Factor Receptor 2 (HER2) and Epidermal Growth Factor Receptor (EGFR) Inhibitors
, 2019; 15(3): 235-247.Ishan I. Panchal*, Ashish Shah, Animesh Devgirkar, Umang Shah, Ashish Patel, Alkesh Patel and Dhrubo J. Sen
DOI: 10.2174/1573394715666181129104528
The Cancer Hygiene Hypothesis: From Theory to Therapeutic Helminths
, 2019; 15(3): 248-250.Ruben Fernandes, Helena Alves and Monica C. Botelho*
DOI: 10.2174/1573394714666181003143717
  |
Editor-in-Chief
Yangchao Chen
School of Biomedical Sciences
Faculty of Medicine
The Chinese University of Hong Kong
Sha Tin
Hong Kong
Biography
View Full Editorial Board
School of Biomedical Sciences
Faculty of Medicine
The Chinese University of Hong Kong
Sha Tin
Hong Kong
Biography
Biography of Yangchao Chen
He is a Principal Investigator at Cancer Biology & Experimental Therapeutics Theme,
School of Biomedical Sciences, CUHK. He is also the Principal Investigator at
Shenzhen Research Institute, CUHK at Shenzhen. He is actively involved in molecular
biology of pancreatic cancer and liver cancer. He is also an active reviewer of
multiple grant agencies and peer-reviewed journals.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Therapy Reviews Journal was launched in 2005. Dr. Yangchao Chen serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net